To identify factors involved in the proliferation defect caused by AP4 loss, we analyzed the expression of CDK2 as we recently identified CDK2 as an AP4-target gene in a genome-wide screen for AP4-regulated genes in a human CRC cell line [7]. This evidence concerns the gene CDK2 and colorectal carcinoma.